Structure Therapeutics Inc (GPCR)
24.03 +0.29 (+1.22%) 13:49 ET [NASDAQ]
24.00 x 42 24.06 x 46
Realtime by (Cboe BZX)
24.00 x 42 24.06 x 46
Realtime - - (-) -
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -122,526 | -89,620 | -51,321 | -38,049 | N/A |
| Depreciation Amortization | -17,473 | -5,680 | -628 | 146 | N/A |
| Accounts payable and accrued liabilities | 3,307 | -860 | 2,153 | 1,897 | N/A |
| Other Working Capital | 2,964 | 6,966 | 2,968 | 4,062 | N/A |
| Other Operating Activity | 17,092 | 9,706 | 708 | -216 | 0 |
| Operating Cash Flow | $-116,636 | $-79,488 | $-46,120 | $-32,160 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -357,619 | -266,175 | -61,953 | 19,065 | N/A |
| PPE Investments | -1,290 | -2,167 | -155 | -1,206 | N/A |
| Investing Cash Flow | $-358,909 | $-268,342 | $-62,108 | $17,859 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 517,059 | 173,096 | 33 | 11 | N/A |
| Common Stock Repurchased | N/A | N/A | -6 | N/A | N/A |
| Other Financing Activity | -1,796 | 278,435 | 28,987 | 103,243 | 0 |
| Financing Cash Flow | $515,263 | $451,531 | $29,014 | $103,254 | $N/A |
| Beginning Cash Position | 129,792 | 26,091 | 105,305 | 16,352 | N/A |
| End Cash Position | 169,510 | 129,792 | 26,091 | 105,305 | N/A |
| Net Cash Flow | $39,718 | $103,701 | $-79,214 | $88,953 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -116,636 | -79,488 | -46,120 | -32,160 | N/A |
| Capital Expenditure | -1,290 | -2,167 | -155 | -1,206 | N/A |
| Free Cash Flow | -117,926 | -81,655 | -46,275 | -33,366 | 0 |